Telix Pharmaceuticals (Belgium)
0695.832.765 · rovalta.com · 24/09/2026
Telix Pharmaceuticals (Belgium)
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOTelix Pharmaceuticals (Belgium) is a Private limited company incorporated in 2018. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Seneffe. It employs on average 51,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0695.832.765
- Incorporation
- 09/05/2018
- Legal form
- Private limited company
- Registered office
- Rue Jules Bordet 55
7180 Seneffe · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 51,0 ETP
Joint committees (3)
- 200
- 207
- 20700
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 14,9 M € | +72.4% | 8,6 M € | – | – | – | |||
| EBITDA | 1,8 M € | +115% | 858,4 k € | +74.2% | 492,7 k € | +120% | -2,5 M € | -5946% | 42,3 k € |
| Operating result | 1 M € | +28.0% | 788,5 k € | +247% | 227 k € | +110% | 108,3 k € | +161% | 41,5 k € |
| Net result | -54,9 k € | -283% | 30,1 k € | +3084% | -1 k € | -102% | 64,2 k € | +128% | 28,2 k € |
| Balance sheet | |||||||||
| Equity | 515,5 k € | -9.6% | 570,4 k € | +5.6% | 540,3 k € | +256% | 151,9 k € | +73.3% | 87,7 k € |
| Total assets | 57,1 M € | +20.3% | 47,5 M € | +117% | 21,9 M € | +219% | 6,9 M € | +23.7% | 5,6 M € |
| Cash | 1,9 M € | +282% | 498 k € | -81.1% | 2,6 M € | +9497% | 27,5 k € | -75.9% | 113,8 k € |
| Debts | 49,7 M € | +24.2% | 40 M € | +126% | 17,7 M € | +407% | 3,5 M € | +479% | 602,6 k € |
| Other | |||||||||
| Workforce | 51,0 ETP | +46.1% | 34,9 ETP | +38.5% | 25,2 ETP | +1382% | 1,7 ETP | +112% | 0,8 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 15 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 31/07/2025 | 30/08/2024 | 14/06/2023 | 15/07/2022 | 03/09/2021 |
| General meeting | 31/07/2026 | 31/07/2025 | 29/08/2024 | 01/06/2023 | 29/06/2022 | 31/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 31/07/2026 | 31/07/2026 | French | |
| Full model | 31/12/2024 | 31/07/2025 | 31/07/2025 | French | |
| Abridged model | 31/12/2023 | 29/08/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 01/06/2023 | 14/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 29/06/2022 | 15/07/2022 | French | |
| Abridged model | 31/12/2020 | 31/08/2021 | 03/09/2021 | French | |
| Abridged model | 31/12/2019 | 26/06/2020 | 06/07/2020 | French | |
| Abridged model | 31/12/2018 | 11/06/2019 | 11/06/2019 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 15 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates24/02/2026DEMISSIONS, NOMINATIONS
- Mandates08/02/2024DEMISSIONS, NOMINATIONS
- Mandates30/10/2023SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates19/10/2022DEMISSIONS, NOMINATIONS
- Mandates08/08/2022DEMISSIONS, NOMINATIONS
- Mandates17/02/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Registered office23/03/2020SIEGE SOCIAL
- Mandates08/01/2020DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-54,9 k €↓
- 2024Annual accounts 202430,1 k €↑
- 2023Annual accounts 2023-1 k €↓
- 2021Annual accounts 202164,2 k €↑
- 2020Annual accounts 202028,2 k €↓
- 2019Annual accounts 201931,8 k €↑
- 2018Annual accounts 201815,3 k €
- 09/05/2018IncorporationPrivate limited company